Company: APXIF
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065703
Chunk: 639

Company: APx Acquisition Corp. I
Filing Date: 2025-07-18
Form: F-4/A
Chunk 639
---
 |   |
| TOTAL LIABILITIES                                    |     |       |     |    5,420,074 |   |     |  4,579,006 |   |
| TOTAL SHAREHOLDERS’ (DEFICIT)/EQUITY AND LIABILITIES |     |       |     |    1,637,438 |   |     |  1,733,353 |   |

The accompanying notes are an integral part of these Unaudited interim condensed Combined Financial Statements.

F-94

OmnigenicsAI Corp
Interim condensed Combined Statements of Changes in Shareholders’ Deficit
For the six-month periods ended December 31, 2024 and 2023
(All amounts in US Dollars, except for share data and otherwise indicated)
(Unaudited)

|                                         |     |   Share 
 capital |     | Capital    
 inflation  
 adjustment |     |     Share 
   Premium |     |  Cumulative 
 translation 
  adjustment |   |     | Accumulated 
 deficit     |   |     |         Total 
 shareholders’ 
       deficit |   |
| Balance as of June 30, 2024             |     |   3,000 |     | —          |     | 4,055,148 |     |      37,682 |   |     | (6,941,483  | ) |     |    (2,845,653 | ) |
| Parent company’s contribution (Note 20) |     |       — |     | —          |     |   410,951 |     |           — |   |     | —           |   |     |       410,951 |   |
| Other comprehensive loss                |     |       — |     | —          |     |         — |     |    (200,548 | ) |     | —           |   |     |      (200,548 | ) |
| Stock based incentive (Note 13)         |     |       — |     | —          |     |   174,920 |     |           — |   |     | —           |   |     |       174,920 |   |
| Net loss for the period                 |     |       — |     | —          |     |         — |     |           — |   |     | (1,322,306  | ) |     |    (1,322,306 | ) |
| Balance as of December 31